Home Cart Sign in  
Chemical Structure| 2055536-64-4 Chemical Structure| 2055536-64-4

Structure of Cintirorgon
CAS No.: 2055536-64-4

Chemical Structure| 2055536-64-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

LYC-55716 is agonist of RAR-related orphan receptor γ (RORγ).

Synonyms: Lyc-55716

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Cintirorgon

CAS No. :2055536-64-4
Formula : C27H23F6NO6S
M.W : 603.53
SMILES Code : FC(F)OC1=CC(F)=CC(C2=CC3=C(O[C@@H](CC(C)(C(O)=O)C)CN3S(C4=CC(C(F)(F)F)=CC=C4)(=O)=O)C=C2)=C1
Synonyms :
Lyc-55716
MDL No. :MFCD31544352
InChI Key :GULSIMHVQYBADX-FQEVSTJZSA-N
Pubchem ID :124126348

Safety of Cintirorgon

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Lewis lung carcinoma (LLC) model Intraperitoneal injection 50 mg/kg Once daily for two weeks Evaluate the antitumor efficacy of LYC-55716 in the LLC model. J Exp Clin Cancer Res. 2022 Apr 23;41(1):155
Sprague Dawley rats Cecal ligation and puncture (CLP)-induced sepsis model Intraperitoneal injection 150 mg/kg Once daily for 7 days To investigate the effect of LYC-55716 on intestinal immune function in septic rats. Heliyon. 2023 Jun 28;9(7):e17766
Wistar rats 14-day-old neonatal rat infection model Oral 10 mg/kg body weight Once every two days, continued until 72 hours post-infection To evaluate the protective effect of Cintirorgon on S. Typhimurium-infected neonatal rats, results showed that Cintirorgon significantly improved survival rates, alleviated weight loss and diarrhea symptoms, and reduced intestinal bacterial load. Emerg Microbes Infect. 2024 Dec;13(1):2417867

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03396497 Non-small Cell Lung Cancer Phase 1 Recruiting March 2019 United States, Colorado ... More >> Lycera Investigational Site Recruiting Aurora, Colorado, United States, 80045 United States, Michigan Lycera Investigational Site Recruiting Ann Arbor, Michigan, United States, 48109 United States, Tennessee Lycera Investigational Site Recruiting Nashville, Tennessee, United States, 37203 United States, Washington Lycera Investigational Site Recruiting Seattle, Washington, United States, 98109 Less <<
NCT02929862 Cancer Phase 1 Phase 2 Recruiting March 2019 -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.66mL

0.33mL

0.17mL

8.28mL

1.66mL

0.83mL

16.57mL

3.31mL

1.66mL

 

Historical Records

Categories